No definition available.
Congenital malformations of eyelid, lacrimal apparatus and orbit
Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
336 |
4. Check minimum number of eventsNone |
336 |
5. Include endpointsNone |
336 |
6. Filter based on genotype QC (FinnGen only) |
336 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q1
- Name in latin
- Malformationes congenitae palpebrarum, apparatus lacrimalis et orbitae
Similar endpoints
↥List of similar endpoints to
Congenital malformations of eyelid, lacrimal apparatus and orbit
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of eye, ear, face and neck
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 12033 | 5863 | 6168 |
| Only index persons | 7548 | 3712 | 3836 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.17 | 0.17 | 0.17 |
| Only index persons | 0.14 | 0.14 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 1.30 | 1.32 | 1.26 |
| Only index persons | 1.36 | 1.40 | 1.32 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 336 | 199 | 137 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.06 |
| Median age at first event (years) | 2.98 | 1.85 | 4.62 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 304
- Matched controls
- 3048
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q10.5
ICD-10 Finland
Congenital stenosis and stricture of lacrimal duct
+∞
183.4
157
*
Q10.0
ICD-10 Finland
Congenital ptosis
+∞
132.1
117
*
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
550.4
86.7
82
*
H02.4
ICD-10 Finland
Ptosis of eyelid
62.3
45.3
52
10
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
178.0
31.3
32
*
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
35.7
27.5
35
11
CCA20
NOMESCO Finland
Incision of lacrimal punctum or canaliculus
76.6
25.3
28
*
CBJ10
NOMESCO Finland
Fascia plate sling or synthetic material for ptosis correction
+∞
20.0
19
*
74482
ICD-8 Finland
Congenital anomalies of eye, Ptosis
+∞
17.9
17
*
Q10.30
ICD-10 Finland
Other congenital malformations of eyelid
+∞
16.8
16
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.8
15.6
133
653
ZXA10
NOMESCO Finland
Bilateral
3.6
14.4
73
248
CBJ30
NOMESCO Finland
Plastic repair of levator aponeurosis of eyelid
146.2
13.6
14
*
Q10.2
ICD-10 Finland
Congenital entropion
+∞
10.5
10
*
ZXE00
NOMESCO Finland
One hour or less
2.3
10.4
132
760
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.6
9.6
79
362
XCK10
NOMESCO Finland
Photography of fundus of eye
4.4
8.6
30
73
CBJ99
NOMESCO Finland
Other operation for ptosis
+∞
8.4
8
*
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
82.0
7.4
8
*
3242
FHL
Levator resection
+∞
7.3
7
*
7436B
ICD-9 Finland
Congenital anomalies of eyelids, lachrymal system and orbit[PTOSIS CONGENITA]
+∞
7.3
7
*
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
30.8
7.2
9
*
WX400
NOMESCO Finland
Inhalation anesthesy
3.7
6.9
29
84
ZXA00
NOMESCO Finland
Right side
2.5
6.8
57
260
H02.3
ICD-10 Finland
Blepharochalasis
7.4
6.8
15
21
Q10.1
ICD-10 Finland
Congenital ectropion
+∞
6.3
6
*
CCD50
NOMESCO Finland
Dacryocystorhinostomy with insertion of tube
+∞
6.3
6
*
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
4.2
6.2
22
55
H53.0
ICD-10 Finland
Amblyopia ex anopsia
5.8
6.1
16
29
ZXA05
NOMESCO Finland
Left side
2.4
6.0
53
249
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023323) Follitropin [Units/volume] in Serum or Plasma
31
152
2.14
3.59
1.7
2.1
iu/l
11.9
12.8
0.10
26
120
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
294
2664
1.83
3.35
11.7
11.3
mg/l
24.9
21.5
0.73
219
1934
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
8
15
5.43
3.21
1.6
1.7
%
135.6
124.7
—
8
15
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
6
8.43
2.75
1.0
1.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
29
156
1.94
2.66
1.9
2.2
u/l
6.6
6.9
0.08
23
122
(3017446) Testosterone [Moles/volume] in Serum or Plasma
30
166
1.89
2.54
1.4
2.1
nmol/l
10.1
12.6
0.61
25
147
(3019309) Folate [Moles/volume] in Red Blood Cells
39
241
1.70
2.32
1.6
1.6
nmol/l
932.9
1135.6
1.04
31
178
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
18
3.95
2.26
1.9
1.7
%
120.3
108.9
—
7
18
(3005322) IgE [Units/volume] in Serum or Plasma
37
229
1.69
2.19
1.4
1.4
u/ml
262.1
361.3
0.22
31
214
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
10
5.05
2.07
3.6
1.3
%
62.0
126.8
—
5
10
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
57
0.00
2.07
0.0
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
296
2767
1.58
2.00
11.5
9.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
21
114
1.90
1.92
2.4
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
113
918
1.35
1.78
4.0
4.5
e6/l
69.3
92.2
0.16
85
619
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
104
836
1.35
1.75
3.9
4.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
221
1981
1.34
1.74
3.4
3.4
pmol/l
14.7
14.5
0.53
201
1789
(3000850) Epithelial cells [#/volume] in Urine
69
519
1.41
1.73
2.7
2.9
e6/l
7.5
8.2
0.14
60
456
(40768804) Tissue Pathology biopsy report
90
710
1.36
1.70
1.8
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
80
620
1.38
1.68
2.5
2.6
u/l
48.9
57.6
1.62
74
563
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
86
676
1.37
1.66
1.9
1.6
pmol/l
96.9
96.5
0.02
48
353
(40765089) Chromosome analysis panel - Blood by G-banded
8
32
2.53
1.60
1.0
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
264
2443
1.37
1.60
13.3
12.6
mmol/l
3.9
3.9
0.47
258
2364
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
43
300
1.50
1.59
2.2
2.3
u/l
2904.1
3186.6
0.03
13
93
(3035320) C reactive protein [Mass/volume] in Body fluid
6
20
3.03
1.58
2.2
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
35
234
1.55
1.57
1.4
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
89
712
1.34
1.53
3.2
3.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
23
139
1.70
1.52
1.3
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
41
286
1.49
1.52
2.7
2.8
%
18.8
23.9
1.71
34
262
(3022621) pH of Urine by Test strip
22
132
1.71
1.50
2.6
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
32
212
1.56
1.50
1.1
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
9
37
2.47
1.49
3.8
3.7
%
82.7
98.5
—
9
37
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
37
2.47
1.49
1.4
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
88
709
1.33
1.44
3.4
3.8
e6/l
0.4
0.3
0.13
69
529
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
124
1048
1.29
1.43
5.4
7.0
umol/l
17.6
18.5
0.08
114
978
(3002582) Erythrocytes [#/volume] in Urine
94
767
1.31
1.40
3.6
3.9
e6/l
8.1
129.4
0.82
76
587
(3009542) Hematocrit [Volume Fraction] of Blood
285
2687
1.40
1.40
13.3
13.0
%
39.4
40.1
0.73
228
2271
(3019550) Sodium [Moles/volume] in Serum or Plasma
262
2441
1.33
1.37
13.5
12.6
mmol/l
139.5
139.5
0.17
256
2367
(3023368) Bacteria identified in Blood by Culture
64
495
1.36
1.37
6.0
4.3
—
—
—
0
0
(3036489) Thrombin time
21
128
1.68
1.36
4.0
7.7
s
21.8
22.8
0.55
21
121
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
279
2625
1.37
1.36
7.9
8.5
u/l
24.6
25.3
0.34
274
2537
(3032080) INR in Blood by Coagulation assay
81
653
1.32
1.31
6.8
5.5
inr
1.1
1.1
0.03
34
225
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
71
564
1.33
1.28
2.5
2.9
ng/l
23.9
30.2
0.23
35
281
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
119
1018
1.26
1.21
9.0
10.9
mmol/l
1.2
1.2
0.88
109
949
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
140
0.49
1.11
1.6
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
90
1.70
1.05
3.1
2.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
9
46
1.98
1.04
2.6
15.3
%
1.4
1.5
—
9
41
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
180
1632
1.22
1.04
6.2
6.2
u/l
91.8
93.3
0.11
175
1534
(3022313) Gas panel - Capillary blood
40
301
1.37
1.03
11.1
10.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
77
915
0.79
1.00
3.1
2.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
23
2.19
0.98
1.2
2.8
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
9
50
1.82
0.97
6.8
3.9
kpa
5.3
4.8
—
9
50
(3027315) Oxygen [Partial pressure] in Blood
9
50
1.82
0.97
6.8
3.9
kpa
9.4
9.0
—
9
50
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
183
1.46
0.97
5.9
5.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
259
2447
1.25
0.97
15.8
14.6
%
13.3
13.3
0.06
253
2402
(1616796) Gas panel - Central venous blood
9
51
1.78
0.95
6.3
4.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
37
1.91
0.94
1.6
1.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
6
27
2.24
0.94
4.0
3.6
mmol/l
5.6
6.4
—
6
27
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
113
986
1.22
0.94
2.9
2.8
nmol/l
73.8
69.9
0.70
104
909
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
55
1.84
0.93
1.3
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
315
3059
1.47
0.93
18.0
16.1
e9/l
264.4
262.1
0.27
305
2962
(3045414) Leukocytes [Presence] in Urine
14
87
1.64
0.89
1.9
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
30
2.02
0.87
1.2
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
6
30
2.02
0.87
4.0
3.3
mmol/l
1.2
1.3
—
6
30
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
55
669
0.79
0.87
2.0
1.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
315
3064
1.44
0.86
17.9
15.9
fl
87.8
88.1
0.51
309
3022
(40768797) Stomach Pathology biopsy report
31
232
1.37
0.85
1.3
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
315
3065
1.44
0.84
18.0
16.0
e12/l
4.6
4.6
0.26
302
2964
(3035941) MCH [Entitic mass]
315
3065
1.44
0.84
17.9
15.9
pg
29.4
29.5
0.77
310
3024
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
243
2294
1.21
0.84
4.2
4.0
mu/l
1.9
1.9
0.15
227
2138
(3013826) Glucose [Moles/volume] in Serum or Plasma
148
1338
1.19
0.83
5.8
6.6
mmol/l
6.2
6.1
0.04
140
1219
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
15
97
1.57
0.82
10.3
16.5
%
0.7
0.7
0.01
15
97
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
73
855
0.81
0.82
2.9
2.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
47
1.72
0.81
1.0
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
315
3068
1.42
0.80
18.0
16.0
e9/l
6.9
6.9
0.12
302
2966
(44813793)
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
25
0.00
0.79
0.0
1.9
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
315
3069
1.42
0.79
18.3
16.2
g/l
134.8
135.3
0.26
310
3025
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
44
352
1.29
0.78
11.2
9.9
mmol/l
1.3
1.0
0.28
32
250
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
124
1.48
0.76
1.6
3.3
ml/min/173m2
89.3
77.5
—
8
51
(3026389) Candida sp identified in Specimen by Organism specific culture
6
34
1.78
0.76
1.7
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
59
1.72
0.76
1.5
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
28
0.00
0.76
0.0
4.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
28
0.00
0.76
0.0
4.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
53
1.72
0.76
2.3
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
113
1005
1.19
0.75
6.3
8.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
46
373
1.27
0.74
11.7
14.9
mmol/l
24.9
24.5
0.48
46
373
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
38
1.86
0.74
2.9
4.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
44
355
1.28
0.74
11.2
9.9
kpa
5.2
5.1
0.43
44
340
(3013650) Neutrophils [#/volume] in Blood by Automated count
175
1617
1.17
0.73
9.3
10.1
e9/l
3.9
3.8
0.10
155
1374
(3042936) Bacteria identified in Isolate by Culture
37
293
1.29
0.71
2.4
2.1
—
—
—
0
0
(3044889) 12 lead EKG panel
140
1273
1.17
0.71
3.0
2.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
39
313
1.28
0.69
2.1
1.7
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
5
27
1.86
0.68
2.4
2.3
umol/l
11.5
12.2
—
5
27
(3030981) Hyaline casts [#/volume] in Urine by Automated count
15
102
1.49
0.68
3.4
3.7
e6/l
0.1
0.1
0.26
15
96
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
136
1.42
0.68
1.8
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
121
1092
1.17
0.67
9.0
10.4
mmol/l
1.2
1.2
0.94
108
966
(1761482) Bacteria [#/volume] in Urine by Culture
7
43
1.64
0.67
3.1
3.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
251
1.30
0.67
2.2
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
56
471
1.23
0.67
2.8
3.6
mg/l
1.2
1.3
0.02
32
336
(3001122) Ferritin [Mass/volume] in Serum or Plasma
144
1318
1.16
0.66
3.6
3.1
ug/l
79.6
64.0
0.62
134
1233
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
28
1.80
0.66
1.4
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
28
1.80
0.66
1.0
2.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
37
298
1.27
0.64
11.8
10.4
kpa
9.1
9.5
0.57
37
285
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51
428
1.23
0.63
3.3
3.5
e6/l
1.2
1.0
0.26
32
241
(3019150) Specific gravity of Urine by Refractometry
68
588
1.20
0.62
4.5
3.0
kg/l
1.0
1.0
0.38
14
87
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
23
174
1.35
0.61
6.1
7.5
ng/l
74.3
62.4
0.26
18
163
(3009508) Creatinine [Moles/volume] in Urine
58
674
0.83
0.61
3.8
3.8
mmol/l
8.9
8.3
0.28
52
599
(3027801) Oxygen [Partial pressure] in Arterial blood
21
157
1.36
0.60
8.2
14.7
kpa
14.7
13.9
0.21
21
152
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
21
157
1.36
0.60
8.2
14.7
kpa
5.4
5.2
0.28
21
151
(3003694) ABO and Rh group [Type] in Blood
100
896
1.16
0.60
1.6
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.2
—
184.4
—
0
21
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
35
1.73
0.58
1.5
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
49
414
1.21
0.57
1.3
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
12
171
0.69
0.56
2.1
2.2
—
11.5
—
0
9
(3011397) Hemoglobin [Presence] in Urine by Test strip
66
575
1.18
0.56
4.3
3.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
10
65
1.55
0.56
2.8
4.0
umol/l
36.2
38.7
—
10
59
(40758558) Short blood count panel - Blood
85
758
1.16
0.55
6.8
8.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
60
1.51
0.54
2.0
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
157
1464
1.14
0.53
7.4
8.3
e9/l
0.2
0.2
0.82
142
1274
(3048689) Calprotectin [Mass/mass] in Stool
59
512
1.18
0.53
2.6
2.5
ug/g
158.4
100.8
0.41
45
392
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
98
0.61
0.53
1.5
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
9
63
1.44
0.52
4.6
3.3
ug/l
128.0
285.5
—
9
55
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
39
325
1.23
0.52
3.7
4.8
umol/l
6.2
8.3
0.52
32
267
(3019198) Lymphocytes [#/volume] in Blood
159
1487
1.13
0.51
7.0
7.6
e9/l
2.3
2.2
0.14
142
1303
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
65
1.39
0.51
1.3
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
114
1044
1.14
0.51
4.2
4.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
152
1418
1.13
0.51
7.2
7.7
e9/l
0.6
0.6
0.58
136
1207
(3023511) Choriogonadotropin [Units/volume] in Urine
13
178
0.72
0.50
1.5
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
206
1960
1.13
0.49
3.5
3.1
mmol/l
5.5
5.6
0.39
185
1804
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
21
163
1.31
0.49
1.2
1.2
u/ml
0.1
1.9
1.62
12
91
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
73
649
1.16
0.49
3.2
2.3
mg/l
2.7
2.7
0.06
66
561
(36660697) Celiac disease serology panel - Serum
44
375
1.20
0.48
1.3
1.2
—
—
—
0
0
(44806118)
7
47
1.50
0.48
2.3
1.9
—
—
—
0
0
(44790047)
7
47
1.50
0.48
2.3
1.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
47
1.50
0.48
4.4
7.6
—
—
—
0
0
(44790048)
7
47
1.50
0.48
2.3
1.9
—
—
—
0
0
(44790049)
7
47
1.50
0.48
2.3
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
79
876
0.87
0.47
1.6
1.6
g/l
1.7
1.8
0.33
41
476
(3006315) Basophils [#/volume] in Blood
152
1423
1.12
0.47
7.2
7.6
e9/l
0.0
0.0
1.57
136
1210
(3018418) pH of Serum or Plasma
63
556
1.16
0.47
3.6
3.8
ph
7.4
7.4
0.32
14
104
(40760892) CBC W Ordered Manual Differential panel - Blood
53
605
0.85
0.46
5.7
5.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
49
1.44
0.46
1.0
1.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
148
1.30
0.44
1.1
1.2
u/ml
0.2
1.1
0.99
11
92
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
51
1.38
0.44
1.4
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
131
0.68
0.44
2.7
1.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
11
78
1.42
0.43
10.6
5.8
%
55.6
52.3
0.18
11
78
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
94
0.63
0.42
1.5
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
94
0.63
0.42
1.5
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.2
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
22
271
0.80
0.42
2.1
2.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
30
250
1.22
0.42
2.2
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
41
353
1.18
0.41
3.9
5.0
ng/l
619.0
1020.7
0.53
35
296
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(4306422)
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
79
1.41
0.41
1.1
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
5
34
1.48
0.40
1.4
2.7
—
782.0
—
0
7
(3050129) First trimester maternal screen panel - Serum or Plasma
14
182
0.76
0.40
1.4
1.3
—
—
—
0
0
(3020891) Body temperature
8
61
1.32
0.40
16.1
5.5
—
—
—
0
0
(3013512) EKG study
50
440
1.16
0.39
2.7
3.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
32
375
0.84
0.39
1.6
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
271
1.20
0.39
1.4
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
68
1.33
0.38
1.7
1.7
—
—
—
0
0
(4198724)
5
37
1.36
0.37
1.0
2.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
37
1.36
0.37
1.6
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
81
1.37
0.36
10.6
21.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
17
135
1.27
0.36
2.1
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
121
0.74
0.36
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
121
0.74
0.36
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
121
0.74
0.36
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
121
0.74
0.36
1.3
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
6
42
1.44
0.35
1.3
1.5
u/l
22.8
14.5
—
6
37
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
42
1.44
0.35
1.0
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
47
416
1.15
0.35
3.4
3.8
e6/l
4.6
3.2
0.28
28
232
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
43
1.40
0.35
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.5
1.6
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
6
43
1.40
0.35
1.5
2.8
mmol/l
1.7
1.6
—
6
43
(3022096) Basophils/100 leukocytes in Blood
140
1323
1.10
0.35
7.0
7.8
%
0.6
0.6
0.11
134
1249
(3021960) Folate [Moles/volume] in Serum or Plasma
46
407
1.15
0.34
1.6
1.4
nmol/l
16.6
20.6
1.36
40
348
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
44
1.37
0.34
1.7
4.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
33
380
0.85
0.34
1.6
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
86
0.69
0.33
1.3
1.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
46
1.31
0.33
1.7
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
33
379
0.86
0.33
1.6
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
47
1.28
0.32
1.8
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
24
202
1.20
0.32
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
251
2572
0.90
0.32
3.8
3.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
143
1358
1.09
0.32
9.1
9.9
e9/l
0.0
0.0
0.50
120
1059
(3000764) Benzodiazepines [Presence] in Urine
33
377
0.86
0.31
1.6
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
138
1.24
0.31
5.2
3.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
15
120
1.26
0.30
2.1
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
11
84
1.32
0.30
4.5
8.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
10
130
0.76
0.30
2.5
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
54
489
1.12
0.30
2.7
3.0
mosm/kgh2o
582.5
566.7
0.17
47
422
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
56
1.25
0.29
1.4
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
204
1973
1.09
0.28
9.2
8.8
ml/min/173m2
102.2
100.6
0.41
157
1467
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
16
194
0.82
0.28
3.8
3.8
%
24.6
21.7
—
10
77
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
21
177
1.20
0.28
3.2
2.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
20
236
0.84
0.27
3.6
3.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
66
1.22
0.27
1.5
2.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
66
1.22
0.27
1.0
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
61
561
1.11
0.26
2.4
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
201
1947
1.08
0.26
3.6
3.4
mmol/l
2.8
2.7
0.85
187
1825
(3035637) Corticotropin [Mass/volume] in Plasma
5
71
0.70
0.26
1.0
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
19
160
1.20
0.26
3.5
4.3
%
0.5
0.3
—
6
33
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
73
1.24
0.25
1.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
73
1.24
0.25
1.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
73
1.24
0.25
1.0
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
39
350
1.13
0.25
2.1
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
137
0.80
0.25
1.1
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
11
87
1.27
0.24
1.1
1.1
u/ml
0.1
0.6
—
5
31
(40768443) Skin Pathology biopsy report
9
77
1.17
0.24
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
77
1.17
0.24
2.0
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
148
1421
1.07
0.24
6.9
7.3
%
54.0
52.4
0.73
142
1349
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
38
1.32
0.23
1.0
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
40
362
1.12
0.23
1.1
1.2
iu/ml
15.3
26.4
0.98
11
96
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
52
478
1.10
0.23
2.3
2.0
—
—
—
0
0
(3000492) Spirometry study
25
219
1.15
0.23
1.3
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
31
346
0.89
0.22
10.2
8.8
mmol/l
0.8
0.8
0.58
31
326
(3021879) Hepatitis B virus core Ab [Presence] in Serum
25
283
0.87
0.22
1.2
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
108
1132
0.93
0.22
1.9
1.9
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
11
0.00
0.21
0.0
3.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
18.5
—
0.6
—
0
11
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
10.2
—
0
11
(3010503) CD19 cells [#/volume] in Blood
0
11
0.00
0.21
0.0
2.9
—
0.2
—
0
11
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
6.0
—
163.9
—
0
10
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
10
0.00
0.21
0.0
1.0
—
159.3
—
0
10
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
10
0.00
0.21
0.0
7.5
—
—
—
0
0
(4211845)
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
25
282
0.88
0.21
1.6
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
0.7
—
0
12
(3005011) Chlamydia sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
2.1
—
0
8
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
48
1.25
0.20
1.3
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
14
0.00
0.20
0.0
3.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
50
1.20
0.20
1.0
1.3
—
4.0
—
0
6
(3016879) Cocaine [Presence] in Urine
32
353
0.90
0.19
1.6
1.9
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
17
146
1.17
0.19
1.2
1.2
u/ml
1.3
4.5
—
7
43
(3002032) Base excess in Venous blood by calculation
41
376
1.10
0.19
6.1
9.3
mmol/l
0.8
1.1
0.24
31
280
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
51
1.18
0.19
1.0
1.3
—
11.8
—
0
8
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
21
237
0.88
0.18
4.6
5.4
u/l
308.0
264.2
0.22
21
230
(3021440) Promyelocytes/100 leukocytes in Blood
19
166
1.15
0.18
5.1
5.2
%
0.1
0.1
—
7
44
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
60
1.17
0.18
1.3
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
16
138
1.17
0.17
2.1
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
61
1.15
0.17
1.7
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
74
701
1.07
0.17
2.9
3.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
35
381
0.91
0.17
4.5
4.3
mg/mmol
7.7
57.1
0.58
25
256
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
82
1.23
0.17
1.1
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
19
167
1.15
0.17
13.3
17.8
mg/l
1.1
1.1
0.40
19
162
(3007566) Smooth muscle Ab [Titer] in Serum
5
68
0.73
0.17
1.0
1.6
—
53.3
—
0
12
(1002224) Polysomnography panel
5
69
0.72
0.17
1.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
12
101
1.19
0.16
1.2
1.1
—
9.9
—
0
13
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
139
1.16
0.16
1.4
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
70
1.15
0.16
1.0
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
8
71
1.13
0.16
2.0
1.9
nmol/l
0.3
0.6
—
8
60
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
79
0.75
0.15
1.7
1.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
140
0.85
0.15
1.3
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
79
1.14
0.15
2.1
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
58
613
0.93
0.15
1.9
1.8
—
—
—
0
0
(3019225) pH of Specimen
13
150
0.86
0.15
4.7
4.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
86
0.81
0.14
1.4
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
87
0.80
0.14
1.6
2.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
7
88
0.79
0.14
1.3
1.6
—
0.0
—
0
20
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
189
1850
1.05
0.14
3.1
3.0
mmol/l
1.2
1.2
0.07
175
1744
(3037522) Nuclear Ab [Titer] in Serum
32
346
0.92
0.14
1.3
1.4
titre
651.4
546.0
—
7
60
(42529406) Shigella sp [Presence] in Stool by Culture
10
84
1.20
0.14
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
180
1.12
0.13
1.8
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
76
728
1.06
0.13
2.1
2.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
12
138
0.86
0.13
2.3
2.6
ug/l
0.7
0.6
—
7
86
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
117
0.85
0.13
1.2
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
168
0.89
0.12
1.9
2.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
34
363
0.93
0.11
3.7
3.6
mg/l
43.5
123.6
1.49
23
246
(3026008) Bacteria identified in Urine by Culture
71
682
1.05
0.11
3.3
2.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
28
260
1.08
0.11
1.3
1.2
—
33.1
—
0
8
(3035350) Ketones [Presence] in Urine by Test strip
123
1199
1.04
0.11
4.2
3.3
estimate
0.0
0.0
0.00
22
257
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
16
177
0.90
0.10
1.3
1.4
miu/ml
218.6
270.4
—
10
91
(3002030) Lymphocytes/100 leukocytes in Blood
148
1449
1.04
0.10
7.1
7.5
%
31.5
32.9
0.72
143
1377
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
199
1959
1.04
0.10
3.4
3.2
mmol/l
4.5
4.4
0.30
185
1856
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
14
125
1.12
0.10
1.5
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
18
164
1.10
0.10
5.2
5.2
%
0.0
0.0
—
7
40
(3047181) Lactate [Moles/volume] in Blood
5
45
1.11
0.10
2.6
13.9
mmol/l
1.3
1.2
—
5
38
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
196
1932
1.03
0.09
3.4
3.1
mmol/l
1.4
1.4
0.58
184
1815
(3021601) Nitrite [Presence] in Urine by Test strip
123
1203
1.03
0.09
5.9
4.6
estimate
0.0
0.0
0.00
24
266
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
54
1.11
0.09
1.7
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
134
0.89
0.09
1.3
1.6
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
6
58
1.03
0.08
1.2
1.1
—
4.7
—
0
8
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
283
1.07
0.08
1.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
283
1.07
0.08
1.8
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
179
1764
1.03
0.08
3.9
3.8
mm/h
8.2
8.7
0.32
163
1633
(3006184) Hemoglobin [Mass/volume] in Capillary blood
7
67
1.05
0.08
1.9
2.4
g/l
140.9
131.5
—
7
48
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
73
0.82
0.07
7.3
9.9
—
2985.7
—
0
9
(3017181) Myelocytes/100 leukocytes in Blood
19
176
1.08
0.07
5.3
5.1
%
1.3
0.7
—
7
49
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
8
74
1.08
0.07
1.5
3.2
mmol/l
3.7
3.4
—
8
69
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
65
670
0.96
0.07
3.5
2.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
108
1.11
0.07
1.2
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
14
153
0.91
0.07
1.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
80
0.87
0.07
2.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
84
1.07
0.07
1.4
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
85
1.06
0.07
1.4
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
87
1.04
0.07
1.6
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
29
275
1.06
0.07
1.2
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
164
1661
0.97
0.06
4.8
4.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
105
0.85
0.06
1.0
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
33
345
0.95
0.06
1.3
1.2
u/ml
15.4
4.9
0.32
12
128
(3015377) Calcium [Moles/volume] in Serum or Plasma
68
662
1.03
0.06
4.1
3.0
mmol/l
2.4
2.4
0.04
61
596
(1001926) Buprenorphine [Presence] in Urine by Screen method
28
294
0.95
0.06
1.6
2.0
—
—
—
0
0
(4010399)
14
129
1.09
0.05
1.4
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
123
1211
1.02
0.05
4.2
3.3
estimate
0.0
0.0
0.00
20
258
(3017143) Hepatitis C virus Ab [Presence] in Serum
50
485
1.04
0.05
1.3
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
92
903
1.03
0.05
4.3
3.1
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
13
120
1.09
0.05
1.0
1.0
mu/l
7.0
8.3
0.48
13
113
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
24
230
1.05
0.03
1.6
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
70
712
0.98
0.03
1.6
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
57
561
1.02
0.02
2.9
2.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
96
969
0.99
0.02
1.6
1.6
u/ml
1.3
2.7
0.76
20
199
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
167
1679
0.99
0.01
4.4
4.0
mmol/mol
36.9
37.2
0.17
154
1581
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
147
0.95
0.01
1.3
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
167
0.96
0.01
1.3
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
234
1.03
0.00
1.4
1.3
iu/ml
54.8
141.1
—
5
80
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
232
0.99
0.00
2.6
2.1
—
—
—
0
0
(3006598) pH of Arterial cord blood
10
95
1.05
0.00
1.0
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
34
345
0.98
0.00
3.2
3.8
ng/l
437.3
511.7
0.08
13
199
(3029937) Albumin [Presence] in Urine by Test strip
65
653
0.99
0.00
4.7
3.4
estimate
0.0
0.0
0.00
23
252
(4035726)
13
131
0.99
0.00
1.6
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
26
258
1.01
0.00
5.2
4.3
ug/l
1.8
1.7
0.02
20
227
(3000991) Gas panel - Venous blood
34
335
1.02
0.00
9.9
11.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
96
956
1.01
0.00
2.2
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
179
1.01
0.00
2.2
2.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
5
0.00
0.00
0.0
5.0
—
12.0
—
0
5
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
86.8
—
0
5
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038702) Sodium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
7.2
—
137.2
—
0
5
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
67
0.89
0.00
1.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
9
0.00
0.00
0.0
1.4
—
30.0
—
0
9
(37021550) Renin [Units/volume] in Plasma --upright
0
8
0.00
0.00
0.0
1.5
—
79.5
—
0
8
(40760512) CD34 cells/100 cells in Bone marrow
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
95
0.95
0.00
2.1
2.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.8
—
152.7
—
0
9
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
9
97
0.93
0.00
1.3
1.3
g/l
0.2
0.2
—
9
92
(3015171) Extractable nuclear Ab [Units/volume] in Serum
8
80
1.00
0.00
1.0
1.2
—
1.6
—
0
6
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
13.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
8
0.00
0.00
0.0
1.7
—
8.2
—
0
8
(21494890) Protein electrophoresis panel - 24 hour Urine
0
9
0.00
0.00
0.0
4.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
81
0.99
0.00
1.3
1.2
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
81
0.99
0.00
1.3
1.2
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.2
—
0.5
—
0
6
(3015235) Bicarbonate [Moles/volume] in Capillary blood
7
71
0.99
0.00
10.0
10.7
mmol/l
25.1
23.6
—
7
63
(3017704) Immunofixation for Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
65
0.92
0.00
1.3
3.9
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT | 1.242 [0.85, 1.81] | 0.263 |
| Birth year | 1.0 [0.99, 1.01] | 0.939 |
During the follow-up period (1.1.1998 — 31.12.2019), 61 out of 5131 females with Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT | 1.42 [1.06, 1.9] | 0.018 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 66 out of 5456 males with Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.099% | 0.215% |
| 5 | 0.743% | 1.521% |
| 10 | 2.266% | 4.077% |
| 15 | 4.051% | 7.793% |
| 20 | 7.108% | 12.713% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_EYELID_LACRIMAL_APPARA_ORBIT – Congenital malformations of eyelid, lacrimal apparatus and orbit
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data